Skinvisible (SKVI) Share-based Compensation Growth (3y) (2013 - 2017)
Powered by 
Analysis
Skinvisible (SKVI) Share-based Compensation Growth (3y) (2013 - 2017) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | -83.20% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | -2.48% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 20.81% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | - |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 18.94% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 7.25% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | - |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | 37.22% |
| Sep 30, 2017 | 21.38% |
| Mar 31, 2016 | 138.80% |
| Dec 31, 2015 | -49.58% |
| Dec 31, 2014 | 5.20% |
| Sep 30, 2014 | -5.05% |
| Sep 30, 2013 | -34.29% |